Audited Results of Morepen Laboratories Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	1,681.19	1,554.54	1,537.59	1,338.88	1,449.27
Manufacturing Expenses	44.90	40.62	34.09	23.78	18.93
Personnel Expenses	206.28	177.22	160.28	146.19	150
Selling Expenses	57.56	0	0	0	0
Administrative Expenses	199.02	181.28	210.03	174	149.04
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,569.12	1,401.12	1,375.77	1,261.61	1,320.13
Operating Profit	112.08	153.41	161.82	77.27	129.14
Other Recurring Income	21.50	15.72	12.57	5.76	10.24
Adjusted PBDIT	133.57	169.13	174.38	83.03	139.37
Financial Expenses	16.10	7.10	3.51	1.98	-7.37
Depreciation	29.31	24.44	21.90	18.01	21.19
Other Write offs	0	0	0	0	0
Adjusted PBT	88.17	137.59	148.98	63.04	125.54
Tax Charges	23.21	36.01	38.04	16.80	24.48
Adjusted PAT	64.96	101.58	110.94	46.24	101.06
Non Recurring Items	1.10	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	66.06	101.58	110.94	46.24	101.06
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	66.06	429.78	328.20	217.27	176.03

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article